Abstract
Neurocysticercosis in an Oncology Patient with High Risk Stage 1 Endometrial Cancer
Highlights
This case describes a 53-year-old with locally excised stage 1B (FIGO, 2009) mixed serous and endometroid adenocarcinoma
For intermediate and high risk, early stage endometrial cancer rates of distant metastases are quoted by PORTEC2 as between 5.7-8.3% for those treated with local radiotherapy only [2]
Our patient was due to receive post-operative CarboplatinPaclitaxol chemotherapy followed by vaginal vault brachytherapy
Summary
This case describes a 53-year-old with locally excised stage 1B (FIGO, 2009) mixed serous and endometroid adenocarcinoma. Her disease was high risk endometrial cancer [1] and she went on to have chemotherapy. For intermediate and high risk, early stage endometrial cancer rates of distant metastases are quoted by PORTEC2 as between 5.7-8.3% for those treated with local radiotherapy only [2].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
